Loading...

PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg $134
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg $283
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  3. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  4. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  5. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  6. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  7. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  8. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  9. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  10. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  11. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  12. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  13. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  14. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  15. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  16. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  17. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  18. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  19. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  20. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  21. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  22. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  23. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  24. Hopke A, et al. 2022. iScience. 25:105226. PubMed
  25. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  26. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  27. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  28. Pinto NA, et al. 2023. Cell Death Differ. :. PubMed
  29. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  30. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  31. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  32. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  33. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  34. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  35. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  36. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  37. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  38. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  39. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  40. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  41. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  42. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  43. Cozzolino M, et al. 2023. Int J Mol Sci. 24:. PubMed
  44. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  45. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  46. Roy S, et al. 2023. J Clin Invest. 133:. PubMed
  47. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  48. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  49. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  50. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  51. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  52. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  53. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  54. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  55. Gawish R, et al. 2022. Elife. 11:. PubMed
  56. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  57. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  58. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  59. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  60. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  61. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  62. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  63. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  64. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  65. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  66. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  67. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  68. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  69. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  70. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  71. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  72. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  73. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  74. Sun P, et al. 2015. J Hepatol. . PubMed
  75. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  76. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  77. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  78. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  79. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  80. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  81. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  82. Morales D, et al. 2015. J Virol. 89:337. PubMed
  83. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  84. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  85. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  86. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  87. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  88. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  89. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  90. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  91. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  92. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  93. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  94. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  95. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  96. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  97. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  98. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  99. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  100. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  101. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  102. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  103. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  104. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  105. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  106. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  107. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  108. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  109. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  110. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  111. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  112. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  113. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  114. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  115. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  116. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  117. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  118. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  119. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  120. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  121. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  122. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  123. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  124. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  125. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  126. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  127. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  128. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  129. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  130. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  131. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  132. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  133. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  134. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  135. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  136. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  137. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  138. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  139. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  140. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  141. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  142. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  143. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  144. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  145. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  146. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  147. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  148. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  149. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  150. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  151. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  152. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  153. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  154. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  155. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  156. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  157. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  158. Kim M, et al. 2018. Immunity. 49:151. PubMed
  159. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  160. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  161. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  162. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  163. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  164. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  165. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  166. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  167. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  168. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  169. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  170. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  171. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  172. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  173. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  174. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  175. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  176. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  177. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  178. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  179. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  180. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  181. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  182. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  183. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  184. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  185. Issah Y, et al. 2021. Elife. 10:. PubMed
  186. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  187. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  188. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  189. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  190. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  191. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  192. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  193. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  194. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  195. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  196. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  197. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  198. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  199. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  200. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  201. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  202. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  203. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  204. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  205. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  206. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  207. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  208. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  209. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  210. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  211. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  212. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  213. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  214. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  215. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  216. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  217. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  218. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  219. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  220. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  221. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  222. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  223. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  224. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  225. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  226. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  227. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  228. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  229. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  230. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  231. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
RRID
AB_1186104 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account